New Drugs to Tackle AMR

  • Laabei, Maisem (CoPI)

Project: Research-related funding

Project Details


Total Funding: £16,000

In this multidisciplinary project, we will develop novel antimicrobial compounds to treat Gram positive bacterial infections combining our expertise in drug discovery, organic synthesis, microbiology and molecular microbial ecology and evolution to enhance the ability of the agents to kill bacteria and interfere with biofilm formation. Furthermore, we will assess drug resistance and resilience with a view to deterring the rise of resistant strains. We will address the problem of diminishing efficacy of antimicrobial drugs by rationally targeting a major constituent of Gram-positive bacteria, synthesis of cell wall lipoteichoic acid.
Effective start/end date1/06/2130/11/21

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.